People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

34.53USD
4 Aug 2015
Change (% chg)

-- (--)
Prev Close
$34.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
550,435
52-wk High
$45.45
52-wk Low
$28.52

Search Stocks

Sabella, Lauren 

Ms. Lauren M. Sabella is Chief Commercial Officer of Acorda Therapeutics, Inc. Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and VP of Commercial Development at Altus Pharmaceuticals from May 2006 to September 2008, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as VP of Sales, Eastern Zone, where she led the successful sales launch of Spiriva and ran both Primary Care and Specialty Divisions, including Neurology, Urology and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several brand launches including Mobic, an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.

Basic Compensation

Total Annual Compensation, USD 446,885
Restricted Stock Awards, USD 227,505
Long-Term Incentive Plans, USD --
All Other, USD 385,724
Fiscal Year Total, USD 1,060,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

4,045,180

Michael Rogers

1,295,070

Andrew Blight

1,484,560

Jane Wasman

2,334,280

Enrique Carrazana

1,663,700

Andrew Hindman

5,167,670
As Of  30 Dec 2014
Search Stocks